Madrigal Pharmaceuticals Inc.
Shannon T Kelley (General Counsel) sells MDGL shares
About this filing
Madrigal Pharmaceuticals Inc. (MDGL) filed Form 4 (insider transaction) with the SEC on Nov 6, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Shannon T Kelley · General Counsel
Rule 10b5-1 plan · adopted Jul 31, 2026
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 6, 2026 | S · open-market saleFootnotes F1 | −1,077 | $400.00 | $430,800.00 | 10,397 | Direct |
Footnotes
- F1 This sale was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 31, 2026.
More MDGL filings
- SC 13D/A
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 6, 2026
- 10-Q
Filed Nov 3, 2026
- 8-K
Filed Nov 3, 2026
- 144
Filed Sep 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.